Label: GERIGENTLE-BACITRACIN ZINC- bacitracin zinc ointment
-
Contains inactivated NDC Code(s)
NDC Code(s): 69771-106-34, 69771-106-35 - Packager: Geri-Gentle Corporation
- Category: HUMAN OTC DRUG LABEL
- DEA Schedule: None
- Marketing Status: OTC monograph final
DISCLAIMER: Most OTC drugs are not reviewed and approved by FDA, however they may be marketed if they comply with applicable regulations and policies. FDA has not evaluated whether this product complies.
Drug Label Information
Updated August 30, 2021
If you are a consumer or patient please visit this version.
- Download DRUG LABEL INFO: PDF XML
- Official Label (Printer Friendly)
- SPL UNCLASSIFIED SECTION
- Active ingredient (In each gram)
- Purpose
- Uses
- Warnings
- Directions for Use
- Other information
- Inactive Ingredients
- PRINCIPAL DISPLAY PANEL
-
INGREDIENTS AND APPEARANCE
GERIGENTLE-BACITRACIN ZINC
bacitracin zinc ointmentProduct Information Product Type HUMAN OTC DRUG Item Code (Source) NDC:69771-106 Route of Administration TOPICAL Active Ingredient/Active Moiety Ingredient Name Basis of Strength Strength BACITRACIN ZINC (UNII: 89Y4M234ES) (BACITRACIN - UNII:58H6RWO52I) BACITRACIN 500 [USP'U] in 1 g Inactive Ingredients Ingredient Name Strength PARAFFIN (UNII: I9O0E3H2ZE) MINERAL OIL (UNII: T5L8T28FGP) WHITE PETROLATUM (UNII: B6E5W8RQJ4) LANOLIN (UNII: 7EV65EAW6H) Packaging # Item Code Package Description Marketing Start Date Marketing End Date 1 NDC:69771-106-34 144 in 1 BOX 01/15/2015 1 0.9 g in 1 PACKET; Type 0: Not a Combination Product 2 NDC:69771-106-35 1 in 1 CARTON 01/15/2015 2 28 g in 1 TUBE; Type 0: Not a Combination Product Marketing Information Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date OTC monograph final part333B 01/15/2015 Labeler - Geri-Gentle Corporation (080367686)